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MicroRNAs (miRNAs), a class of small non-coding regulatory RNAs, have been detected
in a variety of organisms ranging from ancient unicellular eukaryotes to mammals. They
have been associated with numerous molecular mechanisms involving developmental,
physiological and pathological changes of cells and tissues. Despite the fact that
miRNA-silencing mechanisms appear to be absent in some Apicomplexan species,
an increasing number of studies have reported a role for miRNAs in host-parasite
interactions. Host miRNA expression can change following parasite infection and the
consequences can lead, for instance, to parasite clearance. In this context, the immune
system signaling appears to have a crucial role.
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INTRODUCTION
MicroRNAs (miRNAs) are small non-coding RNAs from 18 to 24 nucleotides in length, initially
described in Caenorhabditis elegans (Lee and Ambros, 2001). They are involved in gene expression
regulation by binding to mRNAs and affecting the translation process (Ambros, 2004). In
a canonical way, miRNAs derive from a long primary transcript, which is processed into a
short precursor (pre-miRNA) by the Drosha enzyme complex. The pre-miRNA has around 70
nucleotides and is exported into the cytoplasm by exportin-5. In the cytosol, RNAse III Dicer
recognizes and cleaves the hairpin loop of the pre-miRNA. One strand of the mature miRNA
duplexes associates with the RNA Induced Silencing Complex to form amiRNA- ribonucleoprotein
complex. Then, it binds to the target sites of mRNAs, predominantly in the 3′- end untranslated
region (UTR) of the target mRNA for translational repression or mRNA cleavage (Lewis et al.,
2005; Bartel, 2009) (Supplementary Figure). Since miRNAs often target many different mRNAs,
an individual miRNA can have a wide range of regulatory functions (Kim, 2005). miRNAs have
been found in all Metazoa studied so far, and are implicated in many cellular processes such as
developmental timing, cell proliferation and death (Ambros, 2004; Bartel, 2004). In humans, more
than 700 miRNAs have been identified and it is hypothesized that they affect translation of almost
30% of human genes (Bartel, 2004; Kim and Kim, 2007).
The importance of miRNAs has been described in many parasitic pathologies. In
schistosomosiasis, a worldwide disease caused by the trematode worm Schistosoma, it have been
shown that miRNAs can regulate development of the parasite and also the hepatic pathology
and several signaling pathways in Schistosoma-infected mice (Zhu et al., 2014). Leishmania, the
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causing agent of leishmaniasis, has been shown to target Dicer1
and to downregulate miR-122 which in consequence result in an
induced liver parasite burden (Ghosh et al., 2013). Furthermore,
alterations in cell host miRNAs have also been described in
macrophages and dentritic cells infected with Leishmania (Frank
et al., 2015; Geraci et al., 2015). In Chagas disease, caused by
the parasite Trypanosoma cruzi, the involvment of miRNAs on
resulting cardiovascular disorders have been recently reported
(Ferreira et al., 2014; Linhares-Lacerda et al., 2015; Navarro et al.,
2015).
The presence of these small regulatory non-coding RNAs
has also been described for the Apicomplexa parasites. This
phylum comprises phylogenetically related taxa (around 5000
species), the majority of which are obligate intracellular
parasites affecting many animal species and responsible for
diseases that significantly impact upon human health (Cavalier-
Smith, 1993). The Apicomplexa include Plasmodium falciparum
and Plasmodium vivax, amongst others, the major causal
agents of human malaria (World Health Organization, 2015);
Toxoplasma gondii, the causative agent of toxoplasmosis (Lüder
and Gross, 2005) and Cryptosporidium parvum, a waterborne
agent of cryptosporidiosis, responsible for outbreaks worldwide
(Guerrant, 1997). Once inside the host, parasites may regulate
gene expression in host cells to improve their abilities to
infect and proliferate inside their respective target cells, such
as epithelial cells (Deng et al., 2004; Amino et al., 2008;
Mcdonald et al., 2013), hepatocytes (Prudêncio et al., 2006;
Sturm et al., 2006), erythrocytes (Michel et al., 1980; Gazzinelli
et al., 2014) and, for some species, specialized immune cells
such as macrophages and dendritic cells (Leng et al., 2009).
Usually, this occurs via inhibition of host immune responses,
including those involved in apoptosis and cytokine production
(Plattner and Soldati-Favre, 2008). A growing body of evidence
has demonstrated that parasites promote modifications on host
miRNA population, underscoring the importance of miRNAs in
parasite-host interactions. Here we review the latest evidence for
alterations induced on host miRNAs by Apicomplexa parasites
(e.g., Cryptosporidium, Plasmodium and Toxoplasma) focusing
on those related to the host’s immune response.
Cryptosporidium
A growing number of functional studies have reported the role
of miRNAs in the human host response to Cryptosporidium.
Evidence from in vitro and in vivo studies indicates that both
innate and adaptive immunity are implicated in the resolution
of cryptosporidiosis and resistance to infection (Akira et al.,
2004; Chen et al., 2005). Several miRNAs involved in the
Toll-like Receptor 4 (TLR-4) and NF-κB signaling pathways
have been well documented in C. parvum infection. Using an
in vitro model of human cryptosporidiosis, Zhou et al. analyzed
C. parvum-induced miRNA expression in cholangiocytes. The
infection was able to induce expression of a series of miRNAs
and among them mir-125b-1, mir-21, mir-30b, and mir-23b-
27b-24-1 cluster genes were transactivated through promoter
binding of the NF-κB p65. Functional inhibition of thesemiRNAs
subset resulted in an increased C. parvum burden (Zhou et al.,
2009). Human cholangiocytes infected with Cryptosporidium
also showed downregulation of let-7 in a NF-κB-dependent
mechanism. As a consequence, there was upregulation of TLR
4 (let-7 target) and a better epithelial defense response against
the parasite (Chen et al., 2007). Moreover, let-7 act together with
miR-98 to control expression of suppressors of inflammatory
cytokine signaling (SOCS/CIS) and proteins (Hu et al., 2010).
Induction of CIS expression enhances IκBα degradation resulting
in NF-κB transcription factor activation. Conversely, negative
feedback regulation of TLR4/NF-κB signaling may be reached by
miR-21 induction after C. parvum infection, as miR-21 targets
PDCD4, a proinflammatory protein that promotes activation of
NF-κB and suppresses interleukin 10 (Sheedy et al., 2010).
In the context of regulation of TLR4/NF-κB-mediated
epithelial responses, miR-27b directly targets KSRP4 and
modulates NOS2 (inducible) mRNA stability following C.
parvum infection (Zhou et al., 2012). Moreover, histone
deacetylases (HDACs) and NF-κB signaling have been described
as regulators of mir-424 and miR-503 suppression, which in turn
promote mucosal antimicrobial defense (Zhou et al., 2013).
In terms of cellular adhesion, C. parvum infection resulted
in decreased miR-221 expression in infected epithelial cells.
Moreover, intercellular adhesion molecule-1 (ICAM-1) was
described as miR-221 direct target. Downregulation of miR-221
is probably involved in increased infiltration of lymphocytes into
the intestinal mucosa (Gong et al., 2011).
Toxoplasma
Initial host global miRNA expression approaches for Toxoplasma
gondii showed that the parasite specifically modulates expression
of important host miRNAs during infection (Zeiner et al., 2010).
After 24 h, T. gondii infection altered around 14% of host
miRNAs in primary human foreskin fibroblasts, which could be
related to the NF-κB activation signaling (Shapira et al., 2002).
Upregulation was confirmed for the host primary transcripts
miR-17∼92 and miR-106b∼25 that are known to play crucial
roles in mammalian cell cycle regulation. In particular, in adult
animals miR-17∼92 and miR-106b∼25 have been shown to
influence the functionally intertwined pathways of apoptosis and
G1/S cell cycle progression by targeting multiple components of
each pathway (Xiao and Rajewsky, 2009).
NF-κB signaling and transactivation by STAT3 binding was
demonstrated to regulate a subset of miRNAs (miR-30c-1, miR-
125b-2, miR-23b-27b-24-1, and miR-17 ∼ 92 cluster genes) that
were induced under T. gondii infection in human macrophages.
These miRNAs are mainly involved in anti-apoptosis in response
to T. gondii infection (Cai et al., 2013). Recent study highlighted
two immunomodulatory miRNAs, miR-146a and miR-155,
important for the cell host response to T. gondii challenge. Both
were induced in mice brains under T. gondii infection, but in a
strain-specific manner (Cannella et al., 2014). Mice challenged
with T. gondii cystogenic (type II) strain showed an exclusive
and significant induction of miR-146a, a key immune and
inflammatory response regulator targeting IRAK1 and TRAF6
(Taganov et al., 2006; Saba et al., 2014). The data indicated
that type II allele ROP 16 (rhoptry protein 16) lacked the miR-
146a suppression activity observed for type I allele. ROP16 is a
phosphotyrosine kinase released from the Toxoplasma rhoptries
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that activates STAT3/6 signaling pathways in the host cell nucleus
(Saeij et al., 2007). Another immunoregulatory miRNA, miR-155
(Faraoni et al., 2009; Vigorito et al., 2013), was induced by all
tested strains. Comparative analysis among strains demonstrated
that ablation of miR-146a affects early parasite burden, leading
to significant differences in interferon (IFN)-γ production and in
long-term survival of mice.
Studies of miRNAs as biomarkers in T. gondii infection have
provided potential candidates. A recent study investigated a
correlation between plasma miRNA levels and T. gondii infection
(Jia et al., 2014) comparing miRNA expression profiles from T.
gondii-infected mice with healthy mice. Among the up-regulated
miRNAs, three of them (mmu-miR-712-3p, mmu-miR-511-5p,
and mmu-miR-217-5p) kept the induced expression in infected
mice with either RH or ME49 strain of T. gondii. Moreover,
the up-regulation of these miRNAs was shown to be a specific
response to T. gondii infection, as challenge with other pathogens
such as Plasmodium berghei, P. yoelii, P. chabaudi and C. parvum,
resulted in down-regulation of these miRNAs. The parasite-
specificity of miR-712-3p, miR-511-5p, and miR-217-5p make
them good biomarkers for T. gondii infection.
Plasmodium
In the Vertebrate Host
Recent studies focusing on miRNA pathways in Plasmodium
falciparum have shown a lack of ortholog candidates to the main
components of Dicer complex and RISC in the P. falciparum
genome (Hall et al., 2005). Sequencing and bioinformatics
analysis of small RNA libraries from P. falciparum infected
erythrocytes (Pf-iE) were not able to identify parasite-specific
miRNAs (Rathjen et al., 2006). Instead, the presence of high levels
of human miR-451 in both infected and healthy red blood cells
(RBC) was reported, leading the authors to suggest that miR-
451 could be functional in the differentiation of erythroid cells.
Further studies also reported the lack of Plasmodium-specific
miRNAs. Curiously, miR-451 was once again detected in RBCs,
with higher expression in Pf-iE (Xue et al., 2008). These data
support the genome lack of Dicer and Argonaute orthologues in
P. falciparum, crucial enzymes in miRNAs biogenesis (Coulson
et al., 2004; Hall et al., 2005).
A better understanding of the miR-451 role in Pf-iE came
from a study using sickle cell (HbS) erythrocytes. In the
context of malaria, a well-established resistance to infection
is associated with this specific cell type (Cholera et al., 2008;
Cyrklaff et al., 2011; Ferreira et al., 2011). Recently, La Monte
and colleagues found a role for miRNAs from HbS erythrocytes
in resistance against malaria (Lamonte et al., 2012). For the
first time, translocation of human miRNAs into the parasite
was characterized, with around 100 human miRNAs detected
within parasites. In particular, miR-451 and let-7i were shown
to be enriched in HbAS and HbSS erythrocytes. The miRNA
uptake profile across the intraerythrocytic developmental cycle
was examined to show that let-7i exhibited high expression
after 16 h of parasite growth, whereas expression of miR-451
peaked after 32 h, indicating a dynamic uptake of miRNAs.
Moreover, the authors demonstrated that these two miRNAs
were able to form chimeric fusions with P. falciparum mRNAs
which implies translational inhibition via impaired ribosomal
loading. Integration of miR-451 into P. falciparum regulatory
PKA (cAMP dependent kinase) transcripts was shown. PKA-R is
crucial to parasite survival (Wurtz et al., 2011) and its suppression
mediated by miR-451 was related to an increased number of
gametocytes. In addition, administration of miR-451 and miR-
223 analog molecules resulted in a significant reduction in the
growth of P. falciparum (46%). This study provided the first
data on human miRNAs regulating Plasmodium gene expression
and suggested the possibility of miRNAs being incorporated into
malaria parasites. Moreover, a very recent study investigated
plasma miRNAs alterations mediated by P. vivax and showed
downregulation of miR-451 and miR-16 in P. vivax malaria
patients (Chamnanchanunt et al., 2015).
Changes in miRNAs expression profile have also been
evaluated in experimental malaria models. Modifications in
liver miRNAs were initially investigated in mice infected with
self-healing P. chabaudi malaria (Delic´ et al., 2011). Here
primary infections, but not secondary infections, could induce
upregulation of hepatic mRNAs related to the immune response
(such as IL-1β, TNF-α, IFN-γ, and NF-κB) and promote
alterations in liver miRNAs. Changes in hepatic miRNAs usually
associated with adaptive immune responses were detected:
miR-26b, MCMV-miR-M23-1-5p, and miR-1274a were found
upregulated and 16 miRNA species (miR-101b, let-7a, let-7g,
miR-193a-3p, miR-192, miR-142-5p, miR-465d, miR-677, miR-
98, miR-694, miR-374*, miR-450b-5p, miR-464, miR-377, miR-
20a*, and miR-466d-3p) were downregulated. The expression
level of the miRNAs related to the immune response remained
unchanged for almost all of them in re-infected mice. Although
the data did not explain the mechanisms underlying the changes
in miRNAs expression, they appear specific for malaria infection
and important in acquired protective immunity against P.
chabaudi. A recent study reported very significant upregulation
of miR-155 in liver after infection with genetically attenuated
parasites (GAP) (Hentzschel et al., 2014). Another immuno-
regulatory miRNA, miR-21 was also shown to be induced in
infected GAP mice. Additionally, GAP injection also induced
TNF-α and IFN-γ expression, two known upstream regulators
of miR-155. The crucial relevance of miR-155 in Plasmodium-
infected liver was demonstrated when the ectopic administration
of miR-155 (AAV-155) reduced the number of GAP injections
necessary to achieve immunity in mice.
The pathogenesis of experimental cerebral malaria (ECM)
is multifaceted and evidence suggests that the host immune
system plays a major role in expression of certain cytokines.
Immune modulation (Hunt and Grau, 2003), apoptosis (Lackner
et al., 2007), leukocyte cytoadhesion (Baptista et al., 2010; Costa
et al., 2011), and possibly hypoxia (Penet et al., 2005) are also
involved. El-Assad et al compared expression levels of selected
miRNAs related with the processes above: let-7i, miR-27a, miR-
150, miR-126, miR-210, and miR-155 (El-Assaad et al., 2011).
Mice with cerebral malaria infected with P. berghei ANKA were
compared tomice infected with non-cerebral malaria strains (Pb-
K173 or PbK) and let-7i, miR-27a, and miR-150 were shown
to be upregulated in brain tissue of P. berghei ANKA infected
mice. While let-7i belongs to the let-7 miRNA family previously
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described to control cellular proliferation and the innate immune
response (O’Hara et al., 2010), miR-150 is highly expressed in
monocytes and is related to cell proliferation and apoptosis. The
authors suggested that miR-150 could be controlling monocyte
accumulation in microvasculature, one of the features of fatal
ECM. miR-27a is involved in apoptosis induction, increased
TNF sensitivity, regulation of T cell proliferation and the NF-
κB signaling pathway during inflammation (Chhabra et al.,
2009; Tourneur and Chiocchia, 2010). Its upregulation was
only observed with the PbA strain (PbK was similar to the
naïve control), suggesting a specific role for this miRNA in the
neurological ECM syndrome.
Taken together, these studies demonstrate the importance
of miRNAs in the host response to Plasmodium infection and
strongly suggest that a reprogramming of miRNA expression
could have a regulatory function in malaria pathogenesis.
In the Invertebrate Host
The malaria parasite-vector interaction has received much
attention as this is a great target step to interrupt and/or
lessen the burden of pathogen transmission (Biron and Loxdale,
2013). An important bottleneck suffered by Plasmodium spp.
during its life cycle occurs when parasites go through the gut
of Anopheles spp. mosquito vectors (Cirimotich et al., 2010).
It was demonstrated that defense responses from Anopheles
spp. beside includes various aspects of innate immunity
(systemic humoral immunity, cell adhesion, redox metabolism
and detoxification), and also extracellular-matrix remodeling,
intracellular local epithelial reactions from the midgut epithelial
cells, and apoptosis (Vlachou et al., 2005). So, comprising a
number of mosquito factors that have been shown to affect
development of Plasmodium parasites in the invertebrate host
(Blandin et al., 2008; Cirimotich et al., 2010).
Initially, several putative miRNAs of Anopheles gambiae, the
most important African malaria vector, were reported based on
similarity to known miRNAs that are conserved in Drosophila
spp. (Lai et al., 2003; Wang et al., 2005; Chatterjee and
Chaudhuri, 2006). The first study of isolated miRNAs from P.
berghei infected midguts was able to identify 18 miRNAs in
A. gambiae (Winter et al., 2007). Aga-miR-34, aga-miR-1175,
and aga-miR-1174 were downregulated in infected blood-fed
midgut samples. On the other hand, aga-miR-989 was induced
by infection. Additionally, Drosha, Dicer I and Argonaute 1
mRNAs silencing promoted better parasite survival. Overall,
these data support an involvement of miRNAs as key players
in the regulation of Anopheles resistance against Plasmodium
invasion and survival (Winter et al., 2007).
By using next generation sequencing, Jain et al. identified
and validated 126 miRNAs in post-blood feeding and infection
in A. stephensi, of which 16 and 13 were regulated during
feeding with parasite-infected or non-infected blood, respectively
(Jain et al., 2014). Upon parasitized blood feeding, a tight-
controlled miRNA expression was observed, suggesting a role
during the gonotrophic cycle in the mosquito. Analysis of
miRNA expression revealed several metabolic pathways as targets
for miRNA regulation, including redox homeostasis and protein
processing machinery components. Most importantly, some
miRNAs (miR-124, miR-305, and miR-309) were identified to
target several genes of immune pathways (Jain et al., 2014). In
a comprehensive analysis of miRNAs in A. gambiae, Biryukova
et al. described species-specific production of dominant mature
miRNAs induced by blood feeding (miR-7, miR-92a, miR-317,
and miR-N3) and by parasitized blood feeding (miR-317 and
miR-2940) (Biryukova et al., 2014).
Finally, although several miRNAs have been identified,
scarce information is available regarding their expression
profile in different stages of parasite maturation within the
host. Further investigation on miRNA roles in vector-parasite
interaction may contribute to a better understanding of parasite
virulence attenuation, which in turn could help hamper malaria
transmission.
CONCLUSIONS
The growing number of articles reporting host miRNAs changes
after parasite infection challenge demonstrates the importance of
these non-coding small RNA molecules for the host response.
A comparative analysis between the Apicomplexan parasites
Toxoplasma, Cryptosporidium and Plasmodium revealed a huge
diversity of miRNAs involved in the host response (Figure 1).
The only miRNA to date whose association with
Cryptosporidium, Toxoplasma and Plasmodium infections
has been validated by functional assays is let-7 (Chen et al., 2007;
Iliopoulos et al., 2009; Zeiner et al., 2010; Delic´ et al., 2011).
Specific characteristics such as host cell type and the particular
biology of the parasite contribute to expression of different host
miRNAs. Some convergence on host responses can be found
on miRNAs associated with mammalian immunity (Table 1).
All the listed miRNAs are related to NF-κB signaling. Some
are common miRNAs among these parasites and others are
apparently specific, such miR-223 (Gazzinelli et al., 2014). For
instance, miR-146 was first identified as an immune system
regulator and acts on the mammalian response to microbial
infection (Baltimore et al., 2008). Expression of mature miR-146
species is responsive to LPS and proinflammatory cytokines,
like TNF (Taganov et al., 2006; Hou et al., 2009). Its expression
was shown to be induced after Plasmodium, Cryptosporidium
and Toxoplasma infections. Even though miR-155 had been
described as non-responsive to Cryptosporidium infection, it is
induced upon Toxoplasma and Plasmodium challenges (Zhou
et al., 2009; Lamonte et al., 2012; Cannella et al., 2014; Hentzschel
et al., 2014). This miRNA is considered an immune-response
molecule sensitive to cytokines and regulated by NF-κB and
the Jnk kinase (O’Connell et al., 2010; Elton et al., 2013). It has
been considered part of the innate immune response because
of its increased expression in macrophages under inflammatory
conditions (Tili et al., 2007; Ceppi et al., 2009; Kohlhaas et al.,
2009; Tang et al., 2010). However, some studies have suggested
that miR-155 is also involved in the adaptive immune response.
Upregulation of miR-155 has been described in activated B and
T (CD4+) cells, although it may be also connected to cytokines
(Yin et al., 2007; Banerjee et al., 2010; Lind and Ohashi, 2014).
Expression of miR-106b (part of the miR-106b-25 cluster and
related to apoptosis), miR-30c and miR-27b was increased upon
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FIGURE 1 | Host miRNAs response upon Apicomplexa parasite challenge. (A) C. parvum infection: in infected mice epithelial cells, the parasite alters
NF-κB-responsive miRNAs. Induction of expression, observed for miR-21 and miR-27b blocks their respective mRNAs, PDCD4 and KSPR4. Downregulation of
KSRP4 modulates iNOS levels (dashed arrow). Decreased levels of let-7 and miR-221 promote upregulation of the TLR4 and ICAM-1 mRNAs, while downregulation
of miR-98 results in SOCS4/CIS increased levels. These host miRNAs promote regulation of the TLR/NF-κB signaling and also target NF-κB-regulated immune or
inflammatory genes. TLR4 (toll-like receptor 4); MAL (MyD88-adapter-like); MyD88 (myeloid differentiation primary response gene 88); PCDP4 (programmed cell death
protein 4); KSRP4 (KH-type splicing regulatory protein 4); ICAM-1 (intercellular adhesion molecule 1); NOS2 (inducible nitric oxide synthase 2). (B) T. gondii infection:
common and strain-specific mice miRNA expression is mediated by NF-κB signaling and STAT3 transactivation. The STAT3 transcription factor binds and regulates
expression of miR-30c, miR-27b, miR-125, and miR-19, which in turn results in an anti-apoptosis response. Strain-specific miRNA expression could also be detected.
Type I, II, and III strains are able to induce miR-155 (black arrow) whereas only the type II strain induces miR-146a expression (red arrow). Strains expressing type I or
III ROP16 alleles suppress miR-146a (blue arrow). Deficiency of this miRNA is related with a better control of parasite burden and long-term survival in infected mice.
(C,D) Plasmodium infection. (C) Development cycle of Plasmodium spp. begins with (1) sporozoites, the parasite forms injected into the vertebrate host skin by a
mosquito, invasion of liver and development of (2) merozoites, forms that infect erythrocytes. (3) Male and female gametocytes are then generated by some
intra-erythrocytic parasites and (4) taken up by a mosquito. Alterations in mosquito miRNAs occur as a defense mechanism against parasite invasion, resulting in
reduced parasite development and transmission. On the other hand, in the human host bloodstream, P. falciparum infected sickle cells show upregulation of crucial
miRNAs for parasite growth control. High levels of miR-451, let-7, and miR-223 negatively affect parasite growth. (D) In mice, potential regulatory roles for miRNAs in
experimental severe malaria are highlighted by let-7i, miR-27a, and miR-150 (in brain), which were induced by P. berghei challenge. Endothelial liver cells upon P.
chabaudi infection also display miRNA alterations, as evidenced by upregulation of miR-21 and miR-155.
infection with Toxoplasma and Cryptosporidium, whereas no
change (miR-27b) or even downregulation (miR-106 and miR-
30c) was observed after Plasmodium challenge. In Toxoplasma
and Cryptosporidium, miR-106b was responsive to NF-κB
signaling (Sharma et al., 2009). As similar data was reported
for miR-30c, both miRNAs have been considered to be involved
in cell immune responses. The members of the miR-27 family,
miR-27a and miR-27b, are highly expressed in endothelial
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TABLE 1 | miRNAs responsive to Apicomplexa parasites infection.
miRNA Target mRNAs or signaling pathways Apicomplexa parasites References
Cryptosporidium Toxoplasma Plasmodium
let-7 TLR-4; IL-6
√ √ √
Chen et al., 2007; Jain et al., 2014
miR-146 IRAK1-2; TRAF6
√ √ √
* Iliopoulos et al., 2009; Cannella et al., 2014
miR-155 MyD88; TAB2; IKKε; FOXP3; SOCS1 √ √* Taganov et al., 2006; Ceppi et al., 2009; O’Connell
et al., 2010; Tang et al., 2010; Elton et al., 2013;
Hentzschel et al., 2014
miR-106b IL-10
√ √ √
* Kohlhaas et al., 2009
miR-27 KSRP; NOS2; PPARγ √ √ √* Kuehbacher et al., 2007; Baptista et al., 2010
miR-223 TLR3; TLR4; IKKKα √ Chen et al., 2007; Rénia et al., 2012
miR-98 SOCS
√
Hu et al., 2009
*Indicates data from microarray studies without a functional assay. TLR, Toll-like receptor; IL, interleukin; IRAK, IL-1R-associated kinase; TRAF6, TNFR-associated factor 6; MYD88,
myeloid differentiation primary-response protein 88; TAB2, TAK1-binding protein 2; IKK, inhibitor of NF-κB kinase; FOXP3, forkhead box P3; SOCS1, suppressor of cytokine signaling
1; KSRP, KSRP, KH-type splicing regulatory protein; NOS2, inducible nitric oxide synthase 2; PPARγ, peroxisome proliferator-activated receptor-γ.
cells (Kuehbacher et al., 2007), where they are involved in
angiogenesis, and are also present in the central neural system,
controlling apoptosis (Jennewein et al., 2010; Chen et al., 2014).
Upregulation of the miR-27 family is also observed in the
Apicomplexan parasite infection; miR-27a is induced in ECM
(El-Assaad et al., 2011) and miR-27b is associated to the TLR4-
mediated epithelial anti-microbial defense (Zhou et al., 2012) and
apoptosis (Cai et al., 2013).
FINAL REMARKS
One important consideration for the host miRNAs changes
discussed above is that in some cases the expression data are
from microarray analysis and, thus, it underscores the need for
more functional assays to confirm these initial data and the
convergence seen on host response. As expected, the immunity
response emerges as a common parameter. In the case of
malaria, there is evidence for roles for miRNAs in the immune
response (Lamonte et al., 2012), however much remains to
be explored. The diversity of pathological aspects associated
with Plasmodium infection makes it difficult to identify specific
miRNAs as malaria biomarkers. Currently, a combination of cell
sequestration, deformity of RBC and aggregation (Schofield and
Grau, 2005; Van der Heyde et al., 2006; Gazzinelli et al., 2014)
together with immune responses after Plasmodium challenge
(Idro et al., 2005; Van der Heyde et al., 2006) are considered
as mechanisms underlying severe malaria (Rénia et al., 2012).
Besides that, molecular evidences have pointed that severe
malaria is related to the expression of a subset of virulence genes
that encodes parasite ligands for binding to endothelial cells;
through endothelial protein C receptor, for example, in the host
brain (Avril et al., 2012; Claessens et al., 2012; Turner et al., 2013).
The expression of this subset of virulence genes is controlled
by a RNAseII, suggesting virulence factors are also controlled
at a molecular level (Zhang et al., 2014). For the time being,
only miR-27a fits the bridge between immune signaling pathways
and severe malaria, therefore further research should focus
on this area.
Moreover, a relevant perspective for miRNAs can be
highlighted by the recently decribed potential alternative
strategies for cancer therapy which employed mimic and
antagonist miRNA molecules in different tumor scenarios
(Ma et al., 2010; Wang et al., 2012). In the particular
case of protozoan infection, miR-122, already tested for
liver tumor suppression (Thakral and Ghoshal, 2015), has
a protective function against Leishmania. During Leishmania
infection the loss of hepatic miR-122 is related to an
increased parasite burden in patients with visceral leishmaniasis
(Ghosh et al., 2013). In this case, therapeutical targeting
of miR-122 may be helpful in patients with Leishmania
infection.
Finally, for all protozoan pathologies, further miRNA research
may (i) uncover new biomarkers associated with disease
progression, (ii) determine miRNA target genes that can clarify
the roles of miRNAs in pathogenesis and (iii) aid in the discovery
of new therapeutic targets.
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